Vivos Therapeutics (VVOS)
0.69
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 10-Q Vivos Therapeutics, Inc. For: Mar 31
May 20, 2026 5:06 PM - SEC Filing
Vivos Therapeutics (VVOS) Misses Q1 EPS by 7c
May 20, 2026 4:44 PM - StreetInsider
Vivos Therapeutics reports 70% revenue growth in first quarter
May 20, 2026 4:10 PM - StreetInsider
Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update
May 20, 2026 4:10 PM - StreetInsider
Form NT 10-Q Vivos Therapeutics, Inc. For: Mar 31
May 15, 2026 4:08 PM - SEC Filing
Form SCHEDULE 13G Vivos Therapeutics, Inc. Filed by: ARMISTICE CAPITAL, LLC
May 15, 2026 11:06 AM - SEC Filing
Form EFFECT Vivos Therapeutics, Inc.
May 11, 2026 6:04 AM - SEC Filing
Form 424B3 Vivos Therapeutics, Inc.
May 8, 2026 5:11 PM - SEC Filing
Form S-3/A Vivos Therapeutics, Inc.
April 30, 2026 6:08 AM - SEC Filing
Form 8-K Vivos Therapeutics, Inc. For: Apr 22
April 22, 2026 4:25 PM - SEC Filing
Vivos Therapeutics (VVOS) PT Lowered to $2.50 at H.C. Wainwright
April 20, 2026 6:37 AM - StreetInsider
New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Gro
April 18, 2026 10:00 AM - StreetInsider
Vivos Therapeutics (VVOS) PT Lowered to $2.50 at H.C. Wainwright
April 17, 2026 2:06 PM - StreetInsider
Form 8-K Vivos Therapeutics, Inc. For: Apr 15
April 15, 2026 5:15 PM - SEC Filing
Form 10-K Vivos Therapeutics, Inc. For: Dec 31
April 15, 2026 5:01 PM - SEC Filing
Vivos Therapeutics Reports Full Year 2025 Financial Results
April 15, 2026 4:20 PM - StreetInsider
Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call
April 15, 2026 8:45 AM - Globe NewsWire
New to The Street to Broadcast on Fox Business on Monday, April 13, Featuring Virtuix Holdings (NASDAQ:VTIX), Medicus Pharma (NASDAQ:MDCX), YY Group Holdings (NASDAQ:YYGH), Vivos Therapeutics (NASDAQ:
April 11, 2026 12:30 PM - StreetInsider
Form 3 Vivos Therapeutics, Inc. For: Mar 31 Filed by: V-Co Investors 3 LLC
April 10, 2026 4:54 PM - SEC Filing
Vivos Therapeutics raises $2.25 million in private placement
April 7, 2026 12:53 PM - StreetInsider
Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners
April 7, 2026 12:53 PM - Globe NewsWire
Vivos Therapeutics raises $2.25 million in private placement
April 7, 2026 8:56 AM - StreetInsider
Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners
April 7, 2026 8:56 AM - StreetInsider
Form 8-K Vivos Therapeutics, Inc. For: Apr 03
April 3, 2026 4:06 PM - SEC Filing
Form 4 Vivos Therapeutics, Inc. For: Mar 31 Filed by: Skaff Michael C
April 2, 2026 7:34 PM - SEC Filing
Form SCHEDULE 13D Vivos Therapeutics, Inc. Filed by: V-Co Investors 3 LLC
April 2, 2026 6:33 PM - SEC Filing
Form NT 10-K Vivos Therapeutics, Inc. For: Dec 31
March 31, 2026 4:02 PM - SEC Filing
New to The Street Broadcasts Show #740 on Bloomberg Television at 6:30 PM EST Featuring Medicus (MDCX), Acme Markets- Canton Foundation, Alpha Ton Capital (ATON), and Virtuix Holdings (NASDAQ:VTIX)
March 28, 2026 11:00 AM - StreetInsider
Vivos Therapeutics gains Nevada insurance coverage, cuts costs
March 26, 2026 8:45 AM - StreetInsider
Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market
March 26, 2026 8:45 AM - Globe NewsWire
Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market
March 26, 2026 8:45 AM - StreetInsider
Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy
March 17, 2026 8:45 AM - StreetInsider
Full Article List
